首页 / 院系成果 / 成果详情页

Gamma-delta (gamma delta) T cells: friend or foe in cancer development?  期刊论文   WOS高被引论文

  • 编号:
    9d041c53-ff35-42c5-aa15-aa4106ff716e
  • 作者:
  • 语种:
    英文
  • 期刊:
    JOURNAL OF TRANSLATIONAL MEDICINE ISSN:1479-5876 2018 年 16 卷 ; JAN 10
  • 收录:
  • 关键词:
  • 摘要:

    Background: gamma delta T cells are a distinct subgroup of T cells containing T cell receptors (TCRs)gamma and TCR delta chains with diverse structural and functional heterogeneity. As a bridge between the innate and adaptive immune systems,gamma delta T cells participate in various immune responses during cancer progression. Because of their direct/indirect antitumor cytotoxicity and strong cytokine production ability, the use of gamma delta T cells in cancer immunotherapy has received a lot of attention over the past decade.
    Main text: Despite the promising potential of gamma delta T cells, the efficacy of gamma delta T cell immunotherapy is limited, with an average response ratio of only 21%. In addition, research over the past 2 years has shown that gamma delta T cells could also promote cancer progression by inhibiting antitumor responses, and enhancing cancer angiogenesis. As a result,gamma delta T cells have a dual effect and can therefore be considered as being both "friends" and "foes" of cancer. In order to solve the sub-optimal efficiency problem of gamma delta T cell immunotherapy, we review recent observations regarding the antitumor and protumor activities of major structural and functional subsets of human gamma delta T cells, describing how these subsets are activated and polarized, and how these events relate to subsequent effects in cancer immunity. A mixture of both antitumor or protumor gamma delta T cells used in adoptive immunotherapy, coupled with the fact that gamma delta T cells can be polarized from antitumor cells to protumor cells appear to be the likely reasons for the mild efficacy seen with gamma delta T cells.
    Conclusion: The future holds the promise of depleting the specific protumor gamma delta T cell subgroup before therapy, choosing multi-immunocyte adoptive therapy, modifying the cytokine balance in the cancer microenvironment, and using a combination of gamma delta T cells adoptive immunotherapy with immune checkpoint inhibitors.

  • 推荐引用方式
    GB/T 7714:
    Zhao Yijing,Niu Chao,Cui Jiuwei, et al. Gamma-delta (gamma delta) T cells: friend or foe in cancer development? [J].JOURNAL OF TRANSLATIONAL MEDICINE,2018,16.
  • APA:
    Zhao Yijing,Niu Chao,Cui Jiuwei.(2018).Gamma-delta (gamma delta) T cells: friend or foe in cancer development? .JOURNAL OF TRANSLATIONAL MEDICINE,16.
  • MLA:
    Zhao Yijing, et al. "Gamma-delta (gamma delta) T cells: friend or foe in cancer development?" .JOURNAL OF TRANSLATIONAL MEDICINE 16(2018).
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:14 下载次数:0
浏览次数:14
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部